拉米夫定联合其他药物治疗慢性乙型肝炎的研究进展

doi:10.3736/jcim20030219

Abstract

This paper summarized the effects of the treatment of chronic hepatitis B (CHB) by lamivudine combined with traditional Chinese medicine or Western medicine in the past few years. Combined treatment of lamivudine and the other medicine had higher efficiency than lamvudine alone in the treatment of CHB. The Combined treatment should be a tendency of the treatment for chronic hepatitis B. The focal point is that the traditional Chinese recipe produces a multitarget effect in the treatment of CHB. The combined treatment of lamivudine and traditional Chinese recipe can reduce the treatment course and the recurrence rate. Combined treatment of traditional Chinese medicine and Western medicine has notable superiority and broad developing prospect in the treatment of CHB.

Key words: chronic hepatitis B, lamivudine, combined treatment

CLC Number:

R512.62

Tao Chen, Wen-hui Chen. Advances of combined treatment for chronic hepatitis B with lamivudine. Journal of Chinese Integrative Medicine, 2003, 1(2): 146-150.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.3736/jcim20030219

http://www.jcimjournal.com/EN/Y2003/V1/I2/146

TrendMD

References 26

[1]	杜以真, 秦来英, 范桂玲 , 等. 干扰能和拉米夫定联合治疗慢性乙型肝炎临床观察[J]. 临床肝胆病杂志, 2001,17(2):121-122
[2]	梁宫楠 . 慢性乙肝联合疗法的运用进展[J]. 世界今日医学杂志, 2002,3(1):27
[3]	徐克成, 危北海, 姚希贤 , 等. 慢性乙型肝炎治疗——困难与出路[J]. 中国中西医结合消化杂志, 2002,10(1):3-7 doi: 10.3969/j.issn.1671-038X.2001.06.001
[4]	费筠华, 秦来英, 范桂玲 , 等. 干扰素α联合拉米夫定治疗慢性乙型肝炎临床观察[J]. 山东医药, 1999,39(11):3-4 doi: 10.3969/j.issn.1671-7171.2003.07.009
[5]	甄沛林, 司徒国源 . α-2b干扰素联合拉米夫定治疗慢性乙型肝炎[J]. 广东医学, 2000,21(10):890-891
[6]	许家璋, 朱志华, 高蕾 , 等. 拉米夫定、干扰素α联合治疗慢性乙型肝炎近期疗效分析[J]. 江苏医药杂志, 2001,27(6):423-424
[7]	杨丽华, 江应安, 陈晓蓓 . α-干扰素联合拉米夫定抗乙型肝炎病毒复制的临床研究[J]. 中国生化药物杂志, 2001,22(1):42-43
[8]	朱映华, 郑煜煌, 李异 , 等. 拉米夫定联合干扰素α-2b治疗慢性乙型肝炎疗效观察[J]. 中国现代医学杂志, 2001,11(8):53-54
[9]	李胜堂, 李广明 . α-2b干扰素联合拉米夫定治疗慢性乙型肝炎[J]. 传染病信息, 2001,14(2):81 doi: 10.3969/j.issn.1007-8134.2001.02.019
[10]	徐克成, 李绍白, 翁绍纪 , 等. 拉米夫定和泛昔洛韦联合治疗慢性乙型肝炎[J]. 胃肠病学, 2001,6(2):68-71 doi: 10.3969/j.issn.1008-7125.2001.02.002
[11]	阎稳, 贺俊英, 胡玉凤 . 拉米夫定联合单磷酸阿糖腺苷治疗慢性乙型肝炎78例[J]. 河南医科大学学报, 2001,36(7):498-499 doi: 10.3969/j.issn.1671-6825.2001.04.074
[12]	吴国栋, 熊昌清, 关世运 , 等. 膦甲酸钠联合拉米夫定治疗高黄疸慢性乙型肝炎的初步疗效[J]. 肝脏, 2002,7(3):40-41 doi: 10.3969/j.issn.1008-1704.2002.01.020
[13]	朱海丰 . 1999年国际肝病学术会:左旋咪唑涂布剂(+拉米夫定)联合用药专家研讨会(纪要)[J]. 传染病信息, 2000,13(1):12
[14]	刘钦, 李小良, 王召钦 , 等. 拉米夫定联合胸腺肽治疗慢性乙型肝炎68例[J]. 中西医结合肝病杂志, 2001,11(3):172-173
[15]	朱肖鸿 . 苷必妥联用拉米夫定治疗慢性乙型肝炎的疗效观察[J]. 上海医药, 1999,20(5):10-11
[16]	王军, 李勇富, 胡巧玲 , 等. 拉米夫定联合苷必妥治疗慢性乙型肝炎病人的近期疗效[J]. 临床肝胆病杂志, 2001,17(8):167-168
[17]	覃伯强, 安良敏, 梁增伟 . 拉米夫定联合左旋咪唑涂布剂治疗慢性乙型肝炎疗效观察[J]. 传染病信息, 2001,14(3):112
[18]	Liaw YF, Tsai SL, Chien RN , et al. Prednisolone primary enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B[J]. Hepatology, 2000,32(3):663-665 doi: 10.1053/jhep.2000.16662 pmid: 10960466
[19]	王志毅, 郭树华, 赵有蓉 , 等. 拉米夫定联合乙型肝炎疫苗和猪苓多糖治疗慢性乙型肝炎[J]. 现代医药卫生, 2001,17(4):252-253 doi: 10.3969/j.issn.1009-5519.2001.04.002
[20]	李伟林, 赵仙铭, 戴仁舜 . 中药合拉米夫定短程治疗慢性乙型肝炎[J]. 浙江中西医结合杂志, 2002,12(4):225-226
[21]	张建军, 王洪京, 张红 . 叶下珠合剂与拉米夫定联合治疗慢性乙型肝炎40例[J]. 山东中医药大学学报, 2001,25(6):438-439 doi: 10.3969/j.issn.1007-659X.2001.06.014
[22]	蒋亦明, 曹立森, 汪瑶君 , 等. 拉米夫定、治肝灵冲剂联合治疗慢性乙型肝炎近期疗效研究[J]. 临床肝胆病杂志, 2002,18(2):57-58
[23]	史建国 . 拉米夫定联合五味子制剂治疗乙型肝炎48例[J]. 医药导报, 2001,20(9):566
[24]	张子翔 . 博尔泰力、拉米夫定联合治疗慢性乙型肝炎病人的临床观察[J]. 河南职工医学院学报, 2001,13(4):355 doi: 10.3969/j.issn.1008-9276.2001.04.048
[25]	张学武, 周敏, 胡国启 . 拉米夫定联合博尔泰力治疗慢性乙型肝炎临床研究[J]. 临床肝胆并杂志, 2001,17(3):165-166
[26]	唐克诚, 李谦, 杨积明 . 拉米夫定联合峰岭胶囊治疗慢性乙型肝炎疗效观察[J]. 天津中医, 2001,18(2):7-8 doi: 10.3969/j.issn.1672-1519.2001.02.005

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2]	Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3]	Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4]	Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5]	Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6]	Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7]	Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8]	Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9]	Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10]	Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278

Advances of combined treatment for chronic hepatitis B with lamivudine

RichHTML

PDF (PC)

Like

Abstract

Cite this article

Share this article

TrendMD

References 26

Related Articles 4

Metrics

Comments

Recommended 10

[1]	Xian-kui Qin , Ping Li, Mei Han, Jian-ping Liu. Xiaochaihu Tang for treatment of chronic hepatitis B: A systematic review of randomized trials. Journal of Chinese Integrative Medicine, 2010, 8(4): 312-320.
[2]	Rui Wu , Wen-wen Xiong, Yi-ping Jiang, Guo-xian Li. Changes of eye signs in chronic hepatitis B patients with blood stasis syndrome. Journal of Chinese Integrative Medicine, 2010, 8(1): 46-48.
[3]	Lei Wang, Xiao-xia Feng, Wei Zhang, Lian-jun Xing, Pei-yong Zheng, Guang Ji. Relationship between the phenotypes and functions of peripheral blood dendritic cells and the different spleen deficiency syndrome types in patients with chronic hepatitis B. Journal of Chinese Integrative Medicine, 2009, 7(10): 934-939.
[4]	Jin-yu Xia, Yao-yong Zhou, You-yun Zhao. Relationship between hepatitis B virus in gastric mucosa and syndrome of disharmony between liver and stomach in patients with chronic hepatitis B. Journal of Chinese Integrative Medicine, 2005, 3(1): 19-22.